Recent Transactions

16-Nov-23
Pending
~$400 million
United States flag
Target: 

Sonoma-Cutrer Vineyards (Brown-Forman)

United States flag
Acquiror: 
The Duckhorn Portfolio

Advising Brown-Forman, the largest American-owned spirits and wine company, on its sale of Sonoma-Cutrer Vineyards to The Duckhorn Portfolio

27-Sep-23
Undisclosed
United States flag
Target: 

Slayback Pharma LLC

United States flag
Acquiror: 
Azurity Pharmaceuticals

Advised Azurity Pharmaceuticals, a pharmaceutical company specializing in the provision of innovative medicines to overlooked patients, on the acquisition of Slayback Pharma LLC ("Slayback"), a company focused on complex generic and specialty pharmaceutical products

14-Jul-23
$674 million
U.S.A., U.K. flags
Target: 

Juice Plus+

flag not available

Advised Juice Plus+, a global health and wellness company in the direct selling space on a comprehensive recapitalization transaction

01-Jun-23
Pending
Undisclosed
United States flag
Target: 

Interest in Joint Venture with CarepathRx Health System Solutions

United States flag
Acquiror: 
The Cigna Group

Advising Cigna on its investment in CarepathRx Health System Solutions, under Evernorth, Cigna’s health services subsidiary

16-Feb-23
Pending
$220 million
U.S.A., U.K. flags
Target: 

Flavor Specialty Ingredients division of IFF

United Kingdom flag
Acquiror: 
Exponent Private Equity

Sole financial adviser to Exponent, one of the UK’s leading private equity firms, on the acquisition of IFF’s Flavor Specialty Ingredients division, a global leader in the base aromas market

23-Jan-23
Pending
$200 million
United Kingdom flag
Target: 

Clinigen Ltd’s Proleukin

United States flag
Acquiror: 
Iovance Biotherapeutics

Advising Clinigen Ltd, a UK-based global pharmaceutical services company and portfolio company of Triton Partners, on the sale of Proleukin (Interleukin-2 (Aldesleukin)), to Iovance Biotherapeutics, a late-stage biotechnology company developing novel T cell-based cancer immunotherapies

30-Dec-22
$153 million
United States flag
Target: 

Annovera®, Imvexxy®, Bijuva®, and prescription prenatal vitamin products

Australia flag
Acquiror: 
Mayne Pharma

Advised TherapeuticsMD, Inc., an innovative, leading women’s healthcare company on definitive agreements to license its products to Mayne Pharma

03-Nov-22
Undisclosed
United States flag
Target: 

Pixelligent Technologies

United States flag
Acquiror: 
MVolution Partners

Advised Pixelligent Technologies, a leading manufacturer of nanocrystal material used in consumer electronic devices, on its growth capital raise

25-Oct-22
Pending
Undisclosed
United States flag
Target: 

Acreage Holdings

Canada flag
Acquiror: 
Canopy Growth Corporation

Advising Canopy Growth, a leading diversified cannabis company, on the re-organization and consolidation of its U.S. cannabis assets under a new holding company, Canopy USA, and on related investments and debt repurchase transactions

19-Aug-22
$2.2 billion
United States flag
Target: 

GI Alliance

United States flag
Acquiror: 
Apollo Hybrid Value Fund

Advising the management and majority physician owners of GI Alliance, the largest gastroenterology practice in the United States, on its recapitalization and buyout of minority partner, Waud Capital

08-Aug-22
Pending
$3.0 billion
United States flag
Target: 

InSinkErator (Emerson Electric)

United States flag
Acquiror: 
Whirlpool Corporation

Advised Whirlpool Corporation on its announced acquisition of InSinkErator, the world’s largest manufacturer of food waste disposers and instant hot water dispensers for home and commercial use from Emerson Electric for cash consideration of $3.0 billion

30-Jun-22
Undisclosed
United States flag
Target: 

Sands Family

United States flag
Acquiror: 
Constellation Brands, Inc

Advised the Sands Family in connection with the elimination of Constellation Brands' Class B common stock, which included the conversion of each share of Class B common stock into the right to receive one share of Class A common stock plus $64.64 in cash consideration

28-Mar-22
Pending
~$1.4 billion
United Kingdom flag
Target: 

Theramex

United States flag
Acquiror: 
Carlyle and PAI Partners

Advising Carlyle, the leading private equity investor, on the acquisition of Theramex, a Women’s health-focused specialty pharmaceutical company . The acquisition was jointly executed with PAI Partners

28-Mar-22
Pending
$105 million
United Kingdom flag
Target: 

Acacia Pharma Group plc

United States flag
Acquiror: 
Eagle Pharmaceuticals, Inc.

Advising Acacia, a UK-domiciled and Euronext-listed commercial stage biopharmaceutical company, on the sale to Eagle Pharmaceuticals, an integrated pharmaceutical company with R&D, manufacturing and commercial expertise

01-Feb-22
Undisclosed
United States flag
Target: 

Alteon Health

United States flag
Acquiror: 
U.S. Acute Care Solutions

Advised Alteon Health, a portfolio company of New Mountain Capital and national physician-led provider of emergency medicine, hospitalist medicine and post-acute care services, on its sale to U.S. Acute Care Solutions

28-Jan-22
Undisclosed
United States flag
Target: 

Akorn Pharmaceuticals Portfolio of Branded Ophthalmic Products

France flag
Acquiror: 
Laboratoires Théa SAS

Advised Akorn Pharmaceuticals, a specialty pharmaceuticals manufacturer and marketer, on the divestiture of its portfolio of branded ophthalmic products to Laboratoires Théa SAS

08-Dec-21
$240 million
United States flag
Target: 

Alert 360

United States flag
Acquiror: 
My Alarm Center

Advising My Alarm Center, a nationwide provider of security and smart home monitoring services, on the acquisition of Alert 360, a leading competitor in the alarm monitoring industry

10-Nov-21
Undisclosed
United States flag
Target: 

Bell's Brewery

Japan, Australia flags
Acquiror: 
Lion / Kirin

Advised Lion, one of Australasia’s leading beverage companies and a wholly owned subsidiary of Japanese conglomerate Kirin Holdings, on the acquisition of Bell’s Brewery, a leading US independent craft brewery

29-Sep-21
~$1.1 billion
Colombia flag
Target: 

Procaps Group

United States flag
Acquiror: 
Union Acquisition Corp. II (NASDAQ: LATN)

Advised Procaps Group, a leading integrated international healthcare and pharmaceutical company, on its successful business combination with Union Acquisition Corp II (NASDAQ: LATN), a LatAm-focused special purpose acquisition company. Procaps Group now trades on the Nasdaq Global Market under the ticker symbol "PROC"

20-Sep-21
Undisclosed
Spain flag
Target: 

Faes Farma, flagship product Bilastine

United States flag
Acquiror: 
Hikma Specialty USA INC

Advised Faes Farma in the signing of a long-term license agreement for its flagship product Bilastine with Hikma Specialty USA INC, a subsidiary of Hikma Pharmaceuticals PLC, for the United States of America

12-Jul-21
Pending
$1.7 billion
United Kingdom flag
Target: 

Tate & Lyle PLC’s Primary Products business in North America and Latin America (50% stake)

United States flag
Acquiror: 
KPS Capital Partners

Advising Tate & Lyle PLC, a leading UK-based global provider of food and beverage ingredients and solutions, on its sale of a controlling stake in its Primary Products business in North America and Latin America

11-Jun-21
$248 million
United States flag
Target: 

My Alarm Center

United States flag
Acquiror: 
Ad Hoc Group of First Lien Lenders

Advised the Ad Hoc Group of First Lien Lenders on the pre-packaged Chapter 11 restructuring of My Alarm Center, a provider of security and smart home monitoring services

07-Jun-21
Undisclosed
Target: 

Rights to General, Right Guard and Dry Idea brands

flag not available
Acquiror: 
N/A

Advised Henkel on its brand divestment program (including the sale of the General, Right Guard and Dry Idea brands)

01-Jun-21
Undisclosed
United States flag
Target: 

VEP Healthcare

United States flag
Acquiror: 
U.S. Acute Care Solutions

Advised VEP Healthcare, a leading, physician-owned provider of clinical management services in emergent and inpatient settings in the United States, on its merger with U.S. Acute Care Solutions

10-May-21
Pending
N/A
Target: 

International Flavors & Fragrances, Inc.’s Fruit Preparations business

Acquiror: 
Frulact Serviços Partilhados, SA

Advised International Flavors & Fragrances on the divestiture of its European-based Fruit Preparation business to Frulact Serviços Partilhados, SA

07-May-21
N/A
United States flag
Target: 

MindPath Care Centers

United States flag
Acquiror: 
Community Psychiatry

Advised Community Psychiatry, a leading provider of outpatient behavioral health services with a focus on high-quality clinically-driven care, on its acquisition of MindPath Care Centers, deepening its national presence to more than 350 providers across the US

31-Mar-21
$801 million
United States flag
Target: 

Assets of NPC International, a former national Wendy’s and Pizza Hut franchisee

United States flag
Acquiror: 
Flynn Restaurant Group and a consortium of existing Wendy’s franchisees

Advised the Company on its chapter 11 proceedings and $801mm sale through a § 363 process

18-Mar-21
$750 million
Canada flag
Target: 

Canopy Growth Corporation

United States flag
Acquiror: 
King Street Capital Management, L.P.

Advised Canopy Growth, a leading diversified cannabis company, on its US$750 million term loan financing with King Street Capital Management, L.P.

26-Feb-21
$2.0 billion
United States flag
Target: 

MDLIVE

United States flag
Acquiror: 
Cigna

Advising Cigna on the acquisition of MDLIVE, a virtual care delivery platform, by Evernorth, Cigna’s health services portfolio

25-Feb-21
$1.5 billion
United States flag
Target: 

Ascena Retail Group, Inc.

United States flag
Acquiror: 
Sycamore Partners

Advised the Ad Hoc Group of First-Lien Term Loan lenders of Ascena Retail Group, Inc. with respect to (i) negotiation of a restructuring support agreement, including a fully backstopped DIP and exit financing and (ii) a sale of Ann Taylor, LOFT and Lane Bryant as well as the intellectual property assets of the Justice and Catherine’s brands.

19-Feb-21
$33 million
U.S.A., U.K. flags
Target: 

Acacia Pharma Group plc

flag not available
Acquiror: 
N/A

Advised Acacia Pharma Group plc, a US headquartered commercial stage biopharmaceutical company incorporated in England and listed in Belgium, on its placing of 10m new ordinary shares at a price of €2.70 per share

09-Feb-21
Undisclosed
United States flag
Target: 

US Acute Care Solutions

United States flag
Acquiror: 
Apollo Hybrid Value Fund

Advising US Acute Care Solutions, the largest majority physician-owned emergency medicine practice in the United States, on its recapitalization and buyout of minority partner, Welsh Carson

29-Dec-20
$110 million
United States flag
Target: 

Biogix, Inc.

United Kingdom flag
Acquiror: 
Alliance Pharma plc

Advised Biogix, Inc., a leader in the development, research and distribution of clinically tested menopause and perimenopause supplements in the U.S. under the flagship brand Amberen, on its sale to Alliance Pharma plc

13-Nov-20
$495 million
United States flag
Target: 

Libbey, Inc.

flag not available
Acquiror: 
N/A

Advised the Committee of Unsecured Creditors on the in-court restructuring of Libbey, Inc., a leading tableware manufacturer

13-Nov-20
$343 million
United States flag
Target: 

Revlon Consumer Products Corporation

flag not available
Acquiror: 
N/A

Advised Ad Hoc Group of Note Holders with respect to Revlon’s Exchange Offer

16-Oct-20
$430 million
United States flag
Target: 

Alert 360 (Central Security Group, Inc.)

flag not available
Acquiror: 
N/A

Advised the Ad Hoc Group of First Lien Lenders on the out-of-court restructuring of Alert 360 (Central Security Group, Inc.), a leading home-security provider

01-Oct-20
$1.05 billion
United States flag
Target: 

Akorn, Inc.

flag not available
Acquiror: 
First Lien Term Loan Lenders

Advised Ad Hoc Group of First Lien Term Loan Lenders on Akorn’s in-court recapitalization

30-Sep-20
$236 million
United States flag
Target: 

J. Jill, Inc.

United States flag
Acquiror: 
TowerBrook Capital Partners L.P.

Advised TowerBrook Capital Partners L.P., a leading investment management company and majority shareholder of J. Jill, on the comprehensive out-of-court recapitalization of J. Jill 

15-Sep-20
$NA
United States flag
Target: 

Surgery Partners’ Anesthesia Services

United States flag
Acquiror: 
NorthStar Anesthesia

Advised Surgery Partners, a leading owner and operator of surgical facilities, on the divestiture of its anesthesia services business to NorthStar Anesthesia   

12-Aug-20
$225 million
United States flag
Target: 

340B Link

United States flag
Acquiror: 
Omnicell

Advising Omnicell, a leading provider of medication management solutions and adherence tools for health systems and pharmacies, on the acquisition of the 340B Link business from Pharmaceutical Strategies Group (PSG)

01-Jul-20
$225 million
United Kingdom flag
Target: 

Cello Health plc

United States flag
Acquiror: 
Arsenal Capital Partners

Advised Cello Health, a global healthcare-focused advisory firm, on a recommended cash offer for its entire issued share capital from Arsenal Capital Partners, a specialised private equity firm based in the United States

11-Jun-20
$760 million
United States flag
Target: 

CSM Bakery Solutions

United States flag
Acquiror: 
Rhône Group

Advised the Ad-Hoc Group of First Lien and Second Lien Lenders on consensual out-of-court amend & extend

10-Jun-20
$3.9 billion
Denmark flag
Target: 

Global collaboration agreement with Genmab A/S

United States flag
Acquiror: 
AbbVie, Inc

Advised AbbVie, Inc, an NYSE-listed global biopharmaceutical company, on a broad collaboration with Genmab A/S, a leading Danish-listed biotechnology company, to jointly develop and commercialise three next-generation bispecific antibody programs  

03-Jun-20
$NA
United States flag
Target: 

Cerner RevWorks

United States flag
Acquiror: 
R1 RCM

Advised Cerner Corporation, a leader in healthcare information technology, on its sale of its RevWorks revenue cycle management services business to R1 RCM, a leading provider of technology-enabled RCM services

23-Mar-20
$68 million
Target: 

Abacus Health Products, Inc.

Acquiror: 
Charlotte’s Web Holdings, Inc.

Advised Abacus Health Products, Inc., a leader in over-the-counter (“OTC”) topical products combining active pharmaceutical ingredients with cannabidiol (“CBD”) hemp extract, on its sale to the Charlotte’s Web Holdings, Inc., a market leader in hemp-derived CBD wellness products. 

15-Jan-20
$NA
United States flag
Target: 

OurHealth

United States flag
Acquiror: 
General Atlantic

Advised OurHealth, a provider of onsite and near-site employer-sponsored primary care clinics, on its sale to General Atlantic and merger with Marathon Health

20-Dec-19
$50 million
United States flag
Target: 

Destination Maternity Corporation

United States flag
Acquiror: 
Marquee Brands

Advised Destination Maternity Corporation, the largest maternity, apparel specialty retailer in the United States, on the sale of its intellectual property, e-commerce business, marketing partnership business, store-in-store retail business and other assets to Marquee Brands, a US based investment firm, as part of the Company’s Chapter 11 reorganization

19-Dec-19
$13.5 million
U.S.A., Japan flags
Target: 

Nitta Casings and Nitta Casings Canada

Spain flag
Acquiror: 
Viscofan

Advised Viscofan (BME:VIS), the #1 producer of artificial casings for the meat industry worldwide (>30% market share), on the acquisition of Nitta Casings and Nitta Casings Canada (“NCI” and “NCCI”) one of the leading brands in the production of collagen casings in North America, from Nitta Gelatin (TSE:4977)  

15-Dec-19
$45.4 billion
Target: 

Nutrition & Biosciences Division of DuPont de Nemours, Inc.

United States flag
Acquiror: 
International Flavors and Fragrances, Inc.

Advising IFF, a global leader in flavors and fragrances, on its merger with DuPont’s Nutrition & Biosciences Division, creating a clear global leader in the specialty ingredients sector

27-Nov-19
$320 million
United States flag
Target: 

David’s Bridal Inc.

flag not available
Acquiror: 
N/A

Advised David’s Bridal, a leading bridal gown and special occasion dress retailer, on its out-of-court recapitalization

19-Nov-19
$NA
United States flag
Target: 

New Belgium Brewing

Japan, Australia flags
Acquiror: 
Lion / Kirin

Advised Lion, one of Australasia’s leading beverage companies and a wholly owned subsidiary of Japanese conglomerate Kirin Holdings, on the acquisition of New Belgium Brewing, a leading US independent craft brewery

17-Oct-19
$400 million
United States flag
Target: 

Marshall Retail Group

United Kingdom flag
Acquiror: 
WH Smith plc

Advised WH Smith PLC, one of the UK’s leading retailers, on the acquisition of Marshall Retail Group, a market leading US travel retailer with operations across airport, resort and tourist locations, from Brentwood Associates, a consumer-focused private equity firm

26-Jul-19
$518 million
United States flag
Target: 

Crossmark

flag not available

Advised an ad hoc group of lenders on the comprehensive out-of-court recapitalization of Crossmark, a sales and marketing services company that provides solutions for consumer-branded suppliers and retailers

18-Apr-19
$4.8 billion
United States flag
Target: 

Acreage Holdings Inc.

Canada flag
Acquiror: 
Canopy Growth Corporation

Advised Canopy Growth, a leading diversified cannabis company, on its acquisition of Acreage Holdings Inc., a vertically-integrated multi-state cannabis company with its headquarters in New York

28-Jan-19
$NA
United States flag
Target: 

The Laundress Inc.

Netherlands, UK flags
Acquiror: 
Unilever plc

Advised The Laundress Inc., a laundry and home cleaning products brand, on its sale to Unilever, a British-Dutch consumer goods company

19-Dec-18
$NA
Australia flag
Target: 

Starpharma Holdings Limited, patented VivaGel BV® product

Italy, USA flags
Acquiror: 
ITF Pharma, US subsidiary of Italfarmaco S.p.A.

Advised Starpharma Holdings Limited on a US licensing agreement of its patented VivaGel BV® product with ITF Pharma, a US subsidiary of Italfarmaco S.p.A., a privately held European specialty pharmaceutical company

19-Dec-18
$NA
United States flag
Target: 

Pfizer Inc. Consumer Health Business

United Kingdom flag
Acquiror: 
GlaxoSmithKline plc

Advised GlaxoSmithKline plc ("GSK"), the UK listed international pharmaceutical and consumer healthcare company, on the combination of GSK's and Pfizer's Consumer Health businesses to create a world-leading Joint Venture

30-Nov-18
$NA
United States flag
Target: 

Aisthesis

United States flag
Acquiror: 
NAPA Management Services Corporation

Advised Aisthesis, a portfolio company of Triton Pacific Capital Partners, on its sale to NAPA, a portfolio company of American Securities

29-Nov-18
~$200 million
United States flag
Target: 

Primal Nutrition LLC

United States flag
Acquiror: 
The Kraft Heinz Company

Advised Primal Nutrition, makers of Primal Kitchen branded condiments, dressings and sauces, on its sale to Kraft Heinz

26-Nov-18
$880 million
New Zealand flag
Target: 

Restaurant Brands New Zealand Limited

Acquiror: 
Finaccess Capital, S.A. de C.V.

Advised Finaccess Capital, an investment company with a strong presence in the casual dining and quick service restaurant sector, on its 75% partial takeover of Restaurant Brands New Zealand, a corporate franchisee specialising in managing multi-site branded food retail chains (with brands consisting of KFC, Pizza Hut, Taco Bell and Carl’s Jr.)

18-Nov-18
$876 million
United States flag
Target: 

David's Bridal

flag not available
Acquiror: 
N/A

Advised the Ad Hoc Group of the company's $481mm term loan with respect to the company's prepackaged Chapter 11 restructuring

30-Oct-18
$198 million
United States flag
Target: 

InMotion Entertainment Group LLC

United Kingdom flag
Acquiror: 
WH Smith plc

Advised WH Smith plc, one of the UK’s leading retailers, on the acquisition of InMotion Entertainment, the market leading retailer of digital accessories in US airports

24-Oct-18
$41 million
United States flag
Target: 

TeePublic

Australia flag
Acquiror: 
Redbubble

Advised Redbubble, a global online independent artist community and marketplace, on the acquisition of TeePublic, a similar online platform, and associated A$61 million equity raising

15-Oct-18
$1.1 billion
U.K., Ireland flags
Target: 

Greencore Group plc’s US business

United States flag
Acquiror: 
Hearthside Food Solutions LLC

Advised and acted as sponsor to Greencore Group plc, a leading international manufacturer of convenience foods based in Ireland, on the disposal of its entire US business to Hearthside Foods Solutions

15-Aug-18
$3.9 billion
Canada flag
Target: 

Common shares and common share purchase warrants in Canopy Growth

United States flag
Acquiror: 
Constellation Brands

Advised Canopy Growth on a C$5bn investment by Constellation Brands. As consideration for the investment, Constellation received newly issued Canopy common shares and common share purchase warrants

26-Jul-18
$NA
United States flag
Target: 

Walmart (Credit Card Assets)

United States flag
Acquiror: 
Capital One Financial Corporation

Advised Walmart Inc. on its new, long term credit card program agreement with Capital One Financial Corporation

07-May-18
$7.1 billion
Israel flag
Target: 

Frutarom

United States flag
Acquiror: 
International Flavors and Fragrances

Advised IFF, a leading innovator of specialty ingredients, on its acquisition of Frutarom, creating a global leader in Taste, Scent and Nutrition

02-May-18
$3.7 billion
Canada flag
Target: 

Concordia International Corp.

flag not available

Advised an Ad Hoc Group of Cross-over Debtholders on Concordia International’s cross-border Canadian restructuring and recapitalization, including a US$586.5mm common equity private placement, the equitization of ~US$1.7bn of unsecured debt and the partial paydown and exchange of ~US$2.2bn of secured debt

13-Jul-17
$1.5 billion
United States flag
Target: 

L.L.Bean (Credit Card Assets)

United States flag
Acquiror: 
Citibank, N.A.

Advised  L.L.Bean Inc. on a strategic alliance relating to its credit card business with Citibank, N.A.

10-Jan-17
$204 million
United States flag
Target: 

Derma Sciences, Inc.

United States flag
Acquiror: 
Integra LifeSciences Holdings Corporation

Advised Derma Sciences, Inc., a tissue regeneration company focused on advanced wound and burn care, on its sale to Integra LifeSciences Holdings Corporation, a global leader in medical technology

09-Jan-17
$465 million
United States flag
Target: 

Palatin Technologies, Inc. lead product candidate, Rekynda

United States flag
Acquiror: 
AMAG Pharmaceuticals, Inc.

Advised Palatin Technologies, Inc. on the exclusive licensing of North American rights to develop and commercialize RekyndaTM (bremelanotide), an investigational product designed for on-demand treatment for hypoactive sexual desire disorder in pre-menopausal women, to AMAG Pharmaceuticals, Inc.

14-Nov-16
$748 million
United States flag
Target: 

Peacock Foods

U.K., Ireland flags
Acquiror: 
Greencore Group plc

Advised Greencore Group plc, a leading international manufacturer of convenience foods based in Ireland, on the proposed acquisition of Peacock Foods, a manufacturing partner for consumer packaged goods companies in the US.

03-Nov-16
$NA
Switzerland flag
Target: 

Fragrance Resources Group

United States flag
Acquiror: 
International Flavors & Fragrances Inc.

Advised IFF, one of the world’s largest flavors and fragrances businesses, on the acquisition of Fragrance Resources Group, a family-owned fragrance company headquartered in Switzerland

17-Oct-16
$1.4 billion
United States flag
Target: 

Save-A-Lot

Canada flag
Acquiror: 
Affiliate of Onex Corporation

Advised SUPERVALU, Inc., one of the largest grocery wholesalers and retailers in the US, on the sale of its Save-A-Lot business, a leading hard-discount grocery retailer in the U.S., to an affiliate of Onex Corporation 

13-Oct-16
$NA
U.S.A., Canada flags
Target: 

Concordia International Corp

flag not available

Advised the Special Committee of the Board of Directors of Concordia International, a diverse, international specialty pharmaceutical company focused on generic and legacy pharmaceutical products and orphan drugs, on its strategic review process

04-Oct-16
$223 million
U.S.A., U.K. flags
Target: 

US rights to Toprol-XL (AstraZeneca)

Canada flag
Acquiror: 
Aralez Pharmaceuticals Inc.

Advised Aralez Pharmaceuticals Inc., a global specialty pharmaceutical company in connection with the financing of its acquisition of the US rights to cardiovascular drug Toprol-XL (metoprolol succinate) and its Authorized Generic from AstraZeneca.

28-Jul-16
$80 million
United States flag
Target: 

BioD, LLC

United States flag
Acquiror: 
Derma Sciences, Inc.

Advised Derma Sciences, Inc., a tissue regeneration company focused on advanced wound and burn care, on the acquisition of a proprietary regenerative medicine products company BioD, LLC and a concurrent private placement.

28-Jun-16
$NA
Israel flag
Target: 

US rights to an authorized generic version of Adderall XR

United States flag
Acquiror: 
Prasco Laboratories

Advised Teva Pharmaceutical Industries Ltd. on the divestment of the US rights to an authorized generic version of Adderall XR

28-Jun-16
$652 million
Israel flag
Target: 

US rights to 37 approved and 5 pipeline generic products

Australia flag
Acquiror: 
Mayne Pharma Group Limited

Advised Teva Pharmaceutical Industries Ltd. on the divestment of the US rights to 42 generic products

21-Jun-16
$586 million
Israel flag
Target: 

US rights to a broad portfolio of 18 generic products from Teva Pharmaceutical Industries Ltd.

United States flag
Acquiror: 
Impax Laboratories, Inc.

Advised Teva Pharmaceutical Industries Ltd. on the divestment of the US rights to a broad portfolio of 18 generic products to Impax Laboratories, Inc.

20-Jun-16
$NA
Israel flag
Target: 

US rights to 2 generic drug products from Teva Pharmaceutical Industries Ltd.

India flag
Acquiror: 
Zydus Cadila

Advised Teva Pharmaceutical Industries Ltd. on the divestment of the US rights to 2 generic drug products to Zydus Cadila

16-Jun-16
$40 million
Israel flag
Target: 

US rights to 5 generic injectable drug products from Teva Pharmaceutical Industries Ltd.

United States flag
Acquiror: 
Sagent Pharmaceuticals, Inc.

Advised Teva Pharmaceutical Industries Ltd. on the divestment of the US rights to 5 generic injectable drug products  to Sagent Pharmaceuticals, Inc. 

15-Jun-16
$414 million
United States flag
Target: 

Aegerion Pharmaceuticals

Canada flag
Acquiror: 
QLT Inc.

Advised QLT Inc. on its merger with Aegerion Pharmaceuticals and concurrent equity raise to create a rare disease-focused global biopharmaceutical organization

11-Jun-16
$350 million
Israel flag
Target: 

US rights to 8 generic drug products from Teva Pharmaceutical Industries Ltd.

India flag
Acquiror: 
Dr. Reddy’s Laboratories

Advised Teva Pharmaceutical Industries Ltd. on the divestment of the US rights to 8 generic drug products to Dr. Reddy’s Laboratories

04-May-16
$NA
United States flag
Target: 

Portfolio of synthetic royalty and milestone rights on multiple cardiovascular programs

United States flag
Acquiror: 
Ligand Pharmaceuticals

Advised CorMatrix Cardiovascular, a leading medical device company with a differentiated extracellular matrix technology, on the sale of a portfolio of synthetic royalty and milestone rights on multiple cardiovascular programs

02-May-16
$NA
United States flag
Target: 

Fairway Group Holdings Corp.

flag not available

Advised Fairway Group Holdings Corp., a grocery store chain operating fifteen stores in the New York metropolitan area, in connection with its pre-packaged Chapter 11 bankruptcy plan

19-Apr-16
$NA
United States flag
Target: 

Total Care Medicaid Plan

United States flag
Acquiror: 
Molina Healthcare, Inc.

Advised Molina Healthcare Inc., a provider of managed health care services under the Medicaid and Medicare programs, on the acquisition of Universal American’s Total Care Medicaid plan

07-Mar-16
$NA
Germany flag
Target: 

Boehringer Ingelheim

United States flag
Acquiror: 
AbbVie

Advised Boehringer Ingelheim, the world's largest privately held pharmaceutical company, on a global collaboration with AbbVie regarding an investigational monoclonal IL-23 antibody targeting autoimmune diseases. Within the scope of the agreement, AbbVie also acquired an option for the development and commercialisation of BI’s anti-CD-40 antibody.

17-Dec-15
$130 million
Swiss, Netherlands flags
Target: 

Airopack Technology Group AG

United States flag
Acquiror: 
Apollo Global Management, LLC

Advised Airopack Technology Group, developer of a revolutionary all-plastic dispenser, on a €120 million debt and equity investment from funds managed by affiliates of Apollo Global Management, and the concurrently announced proposed acquisition of the 50% stake it does not already own in Airolux AG, its joint venture with Resilux NV

29-Oct-15
$275 million
United States flag
Target: 

Aesynt, Inc.

United States flag
Acquiror: 
Omnicell, Inc.

Advised Omnicell, Inc., a leading supplier to health systems of automation solutions and business analytics software for medication and supply management, on the acquisition of Aesynt, Inc., a provider of integrated pharmacy automation solutions for hospitals and health systems

27-Jul-15
$40.5 billion
Ireland flag
Target: 

Allergan Generics

Israel flag
Acquiror: 
Teva Pharmaceutical Industries Ltd.

Advised Teva Pharmaceutical Industries Ltd., a leading global pharmaceutical company, on the acquisition of Allergan plc’s Generics business

06-Jul-15
$910 million
United States flag
Target: 

Altegra Health, Inc.

United States flag
Acquiror: 
Emdeon Inc.

Advised Emdeon, a leading healthcare information technology company, on the acquisition of Altegra Health, a national provider of technology and intervention platforms for value-based healthcare

02-Jun-15
$NA
United Kingdom flag
Target: 

Portfolio of GlaxoSmithKline plc consumer and OTC brands

United States flag
Acquiror: 
Perrigo Company plc

Advised GlaxoSmithKline plc, a leading British pharmaceutical company, on the disposal of a portfolio of consumer and OTC brands to Omega Pharma NV, a subsidiary of Perrigo Company plc

26-May-15
$2.2 billion
United States flag
Target: 

Nordstrom, Inc. (Credit Card Assets)

U.S.A., Canada flags
Acquiror: 
The Toronto-Dominion Bank Group

Advised The Toronto-Dominion Bank Group on its acquisition of Nordstrom, Inc.’s credit card assets

21-Apr-15
$NA
United Kingdom flag
Target: 

Tate & Lyle plc

United States flag
Acquiror: 
Archer Daniels Midland Company

Advised Tate & Lyle plc, a leading provider of ingredients and solutions to the food, beverage and other industries, on the re-alignment of Eaststarch C.V., its 50:50 corn wet milling joint venture in Europe with Archer Daniels Midland Company

30-Sep-14
$NA
United States flag
Target: 

Masco Corporation

flag not available

Advised Masco Corporation, a leading global provider of home improvement and building products, on the tax-free spin-off of its Installation Services business

11-Aug-14
$NA
United States flag
Target: 

MannKind Corporation

France flag
Acquiror: 
Sanofi

Advised MannKind, a biopharmaceutical company focused on the development of therapeutic products for patients with diabetes, on a collaboration with Sanofi, comprising licensing, supply and loan facility agreements with respect to licensing the Company’s lead product AFREZZA. MannKind will receive up to $925 million in upfront and milestone payments plus 35% of future profits.

05-Aug-14
$1.3 billion
U.S.A., Germany flags
Target: 

Siemens Health Services

United States flag
Acquiror: 
Cerner Corporation

Advised Cerner Corporation, a leader in healthcare information services, on the acquisition of the assets of Siemens Aktiengesellschaft’s healthcare information technology business unit, Siemens Health Services, for $1.3 billion in cash.

28-Jul-14
$90 million
Australia flag
Target: 

Clinuvel Pharmaceuticals Limited

United States flag
Acquiror: 
Retrophin, Inc.

Advised Clinuvel, a biopharmaceutical company focused on developing drugs for the treatment of a range of severe skin disorders, in response to an unsolicited proposal to acquire the business from Retrophin, a pharmaceutical company focused on the development, acquisition and commercialization of drugs for the treatment of serious, catastrophic or rare diseases

01-Apr-14
$NA
United States flag
Target: 

Dillard's, Inc. (Credit Card Assets)

United States flag
Acquiror: 
Wells Fargo & Company

Advised Dillard’s, Inc. on a strategic alliance relating to its credit card business with Wells Fargo & Company

10-Mar-14
$NA
United States flag
Target: 

K-Y brand

United Kingdom flag
Acquiror: 
Reckitt Benckiser Group plc

Advised Reckitt Benckiser, a leading consumer goods manufacturer, on the acquisition of the global rights to the K-Y brand, a leader in intimate lubricants

06-Mar-14
$10.0 billion
United States flag
Target: 

Safeway Inc.

United States flag
Acquiror: 
Albertsons (majority owned by Cerberus Capital Management)

Advised the Board of Directors of Safeway Inc., a leading food and drug retailer, on its acquisition by Albertsons

18-Feb-14
$25.1 billion
United States flag
Target: 

Forest Laboratories Inc.

Ireland flag
Acquiror: 
Actavis plc

Advised Actavis plc, a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products on its acquisition of Forest Laboratories Inc.

05-Feb-14
$NA
Sweden flag
Target: 

Unfors Raysafe AB

United States flag
Acquiror: 
Fluke Biomedical Corporation

Advised the Sixth Swedish National Pension Fund on the sale of Unfors Raysafe AB, a provider of easy-to-use products that help to reduce unnecessary radiation exposure, to Fluke Biomedical Corp., a subsidiary of Danaher Corp. that manufactures biomedical test and simulation products

18-Dec-13
$NA
United States flag
Target: 

Fidelis SeniorCare Inc. (Michigan Heath Plan)

United States flag
Acquiror: 
Centene Corporation

Advised Fidelis SeniorCare Inc., a healthcare provider focused on the care of the elderly, on the sale of a majority of its SecureCare Michigan health plan to Centene Corporation, a managed care provider focused on the Medicaid space

10-Sep-13
$NA
U.S.A., U.K. flags
Target: 

Fresh & Easy (owned by Tesco plc)

United States flag
Acquiror: 
YFE Holdings, Inc (affiliate of The Yucaipa Companies, LLC)

Advised Tesco plc, a listed FTSE 100 retailer, on the sale of a substantive part of Fresh & Easy’s operating business to YFE Holdings, Inc, an affiliate of The Yucaipa Companies, LLC

20-May-13
$8.5 billion
Ireland flag
Target: 

Warner Chilcott, plc

United States flag
Acquiror: 
Actavis, Inc.

Advised Actavis, Inc., a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, branded and biosimilar products on its acquisition of Warner Chilcott plc

10-Jan-13
$3.3 billion
United States flag
Target: 

SUPERVALU, Inc.

United States flag
Acquiror: 
Cerberus Capital Management L.P.

Advised SUPERVALU, a leading food retailer, on the sale of its New Albertsons, Inc. subsidiary to an investor group led by Cerberus Capital Management L.P. In addition to the sale, Greenhill also advised the Company on a simultaneous equity tender offer by Cerberus for up to a 30% stake in pro forma SUPERVALU

23-Oct-12
$5.7 billion
United States flag
Target: 

Target Corporation’s REDcard credit card assets

U.S.A., Canada flags
Acquiror: 
The Toronto-Dominion Bank Group

Advised The Toronto-Dominion Bank Group on its acquisition of Target Corporation’s REDcard credit card assets

20-Aug-12
$7.3 billion
United States flag
Target: 

Coventry Health Care Inc.

United States flag
Acquiror: 
Aetna

Advised Coventry Health Care Inc., a diversified managed health care company that offers a full portfolio of managed care products serving the commercial group and individual, Medicare Advantage, Medicare Part D and Medicaid markets, on its acquisition by Aetna

06-Jul-12
$730 million
Germany flag
Target: 

WMF Württembergische Metallwarenfabrik AG

United States flag
Acquiror: 
Kohlberg Kravis Roberts & Co. L.P.

Provided fairness opinion to the Executive Management Board of WMF in connection with the voluntary public takeover offer by Finedining Capital GmbH, a holding company in the possession of funds managed by Kohlberg Kravis Roberts & Co. L.P.

04-May-12
$55 million
United Kingdom flag
Target: 

Armajaro Trading Limited

United States flag
Acquiror: 
International Finance Corporation

Advised Armajaro Trading Limited, a global soft commodity trading house and supply chain manager, on raising mezzanine capital from the International Finance Corporation, a unit of the World Bank

26-Mar-12
$513 million
United States flag
Target: 

ISTA Pharmaceuticals, Inc.

United States flag
Acquiror: 
Bausch + Lomb, Inc.

Advised ISTA Pharmaceuticals, an ophthalmic pharmaceutical company, on its sale to Bausch + Lomb, Inc., a global ophthalmic products company

16-Dec-11
$NA
United States flag
Target: 

ISTA Pharmaceuticals, Inc.

Advised ISTA Pharmaceuticals, an ophthalmic pharmaceutical company, on its defense against an unsolicited offer from Valeant Pharmaceuticals and on its review of strategic alternatives

21-Nov-11
$689 million
Australia flag
Target: 

iNova Pharmaceuticals

United States flag
Acquiror: 
Valeant Pharmaceuticals

Advised Archer Capital and Ironbridge Capital on the sale of iNova Pharmaceuticals, a leading pharmaceuticals company that sells and distributes a range of prescription and over-the-counter products in Australia, New Zealand, Asia and Southern Africa, to Valeant Pharmaceuticals

07-Nov-11
$398 million
United States flag
Target: 

American Dental Partners, Inc.

United States flag
Acquiror: 
JLL Partners

Advised American Dental Partners, Inc. (NASD: ADPI), one of the nation’s leading business partners to dental group practices, on its sale to JLL Partners, a leading private equity firm

30-Jun-11
$609 million
Japan flag
Target: 

Diabetes-related patent estate and royalty stream of Astellas Pharma subsidiary, Prosidion

United States flag
Acquiror: 
Royalty Pharma

Advised Royalty Pharma, a leading acquiror of biopharmaceutical royalty interests, on the acquisition of the DPP-IV patent estate and associated royalty stream of Astellas Pharma subsidiary, Prosidion

13-Jun-11
$2.3 billion
United States flag
Target: 

The Timberland Corporation

United States flag
Acquiror: 
VF Corporation

Advised VF Corporation, a global leader in branded lifestyle apparel on its acquisition of The Timberland Company, a leading outdoor footwear and apparel company

07-Feb-11
$548 million
United States flag
Target: 

Wesco Financial Corporation

United States flag
Acquiror: 
Berkshire Hathaway Inc.

Advised the Special Committee of Wesco Financial Corporation in connection with Berkshire Hathaway Inc.'s proposal to acquire the remaining 19.9% of the shares of Wesco’s common stock that it does not presently own

15-Dec-10
$12.9 billion
U.S.A., Swiss flags
Target: 

Alcon, Inc.

Switzerland flag
Acquiror: 
Novartis AG

Advised the Independent Director Committee of Alcon, Inc., an ophthalmic pharmaceutical company, on the sale of Alcon’s outstanding publicly held interest to Novartis AG, a global pharmaceutical company

07-Dec-10
$500 million
United States flag
Target: 

Medicity, Inc.

United States flag
Acquiror: 
Aetna Inc.

Advised Aetna Inc. on its acquisition of Medicity, Inc., a leading provider of technology solutions to enable the secure access and exchange of healthcare information

12-Aug-10
$NA
United States flag
Target: 

Kohl’s Corporation

United States flag
Acquiror: 
Capital One Financial Corporation

Private Label Credit Card Business
Advised Kohl’s Corporation on a strategic alliance relating to its private label credit card business with Capital One Financial Corporation

12-Jul-10
$NA
United States flag
Target: 

Breast Care Business of Ethicon-Endo Surgery

United States flag
Acquiror: 
Devicor Medical Products, Inc. (a GTCR portfolio company)

Advised GTCR and Devicor Medical Products, Inc., a portfolio company of GTCR, on the acquisition of the Breast Care Business of Ethicon-Endo Surgery

05-Apr-10
$225 million
United States flag
Target: 

Medegen, Inc

United States flag
Acquiror: 
CareFusion Corporation

Advised Medegen, Inc., a medical device company that develops, manufactures and markets clinically superior disposable intravenous therapy products on its sale to CareFusion, a global medical devices company

25-Feb-10
$14.4 billion
United States flag
Target: 

Coca-Cola Enterprises Inc.

United States flag
Acquiror: 
The Coca-Cola Company

Advised the Affiliated Transaction Committee of Coca-Cola Enterprises Inc. on the sale of its North American bottling operations to The Coca-Cola Company and on its concurrent acquisition of The Coca-Cola Company’s bottling operations in the Nordic region

23-Feb-10
$NA
United States flag
Target: 

Heartscape Technologies, Inc.

United States flag
Acquiror: 
Roper Industries, Inc.

Advised Heartscape Technologies, a medical device company on its sale of substantially all its assets to Roper Industries, a diversified growth company

09-Nov-09
$327 million
United States flag
Target: 

Enzon Pharmaceuticals, Inc.

Italy flag
Acquiror: 
Sigma-Tau Pharmaceuticals

Advised Enzon Pharmaceuticals, Inc., a biopharmaceutical company on the sale of its specialty pharmaceutical business to Sigma-Tau, an Italian pharmaceutical company

10-Aug-09
$596 million
United States flag
Target: 

Barnes & Noble College Booksellers, Inc.

United States flag
Acquiror: 
Barnes & Noble, Inc.

Advised the Special Committee of the Board of Directors of Barnes & Noble, Inc., the world’s largest bookseller, on its acquisition of Barnes & Noble College Booksellers, Inc.

23-Jun-09
$155 million
United States flag
Target: 

Monogram Biosciences, Inc.

United States flag
Acquiror: 
Laboratory Corporation of America Holdings

Advised LabCorp on the acquisition of Monogram Biosciences, a molecular diagnostics company focused on guiding and improving the treatment of serious infectious diseases and cancer

12-Mar-09
$46.9 billion
United States flag
Target: 

Genentech, Inc.

Switzerland flag
Acquiror: 
Roche Holding Ltd.

Advised Roche Holding Ltd., a world-leading provider of healthcare pharmaceuticals and diagnostics, on its acquisition of the outstanding publicly held interest in Genentech, Inc., a leading biotechnology company

12-Jun-08
$6.7 billion
United States flag
Target: 

Applied Biosystems Group

United States flag
Acquiror: 
Invitrogen Corporation

Provided fairness opinion to the Board of Directors of the Applera Corporation on the merger of its Applied Biosystems business, which serves the life science industry, with the Invitrogen Corporation, creating a global leader in biotechnology reagents and systems

23-Apr-08
$2.8 billion
United States flag
Target: 

Wendy's International, Inc.

United States flag
Acquiror: 
Triarc Companies, Inc.

Advised the special committee of the board of directors in connection with its merger with Triarc Companies, Inc., the operator of the Arby’s franchise. The combined systems will have approximately 10,000 restaurant units and pro forma annual system sales of approximately $12.5 billion, positioning it as the nation’s third largest quick service restaurant company

22-Jan-08
$3.4 billion
United States flag
Target: 

Ventana Medical Systems, Inc.

Switzerland flag
Acquiror: 
Roche Holding Ltd.

Advised Roche Holding Ltd., a world-leading provider of healthcare pharmaceuticals and diagnostics, on its acquisition of Ventana Medical Systems, Inc., a US based provider of histopathology diagnostic equipment

16-Jul-07
$2.1 billion
United States flag
Target: 

Applebee’s International, Inc.

United States flag
Acquiror: 
IHOP Corp.

Sole advisor to IHOP Corp., the fastest growing family dining concept in the US, on its acquisition of Applebee's

30-Mar-07
$24.4 billion
United Kingdom flag
Target: 

Alliance Boots plc

United States flag
Acquiror: 
Kohlberg Kravis Roberts & Co. Ltd. and Stefano Pessina

Advised Alliance Boots plc, the leading international pharmacy-led health and beauty group, on a proposal regarding an offer for the company from a consortium comprising of Kohlberg Kravis Roberts & Co. Ltd. and Stefano Pessina

25-Jan-07
$3.3 billion
United States flag
Target: 

Cardinal Health, Inc., Pharmaceutical Technologies and Services division

United States flag
Acquiror: 
The Blackstone Group

Provided fairness opinion to the board of directors of Cardinal Health, Inc., a global company serving the health-care industry, on the sale of its Pharmaceutical Technologies and Services business, which provides outsourced services and proprietary technologies to the global pharmaceutical and biotechnology industries

06-Nov-06
$4.2 billion
United States flag
Target: 

Kos Pharmaceuticals, Inc.

United States flag
Acquiror: 
Abbott Laboratories

Advised Kos Pharmaceuticals, Inc., a specialty pharmaceutical provider of cardiovascular and respiratory drugs, on its sale to Abbott Laboratories

09-Sep-05
$1.0 billion
United States flag
Target: 

7-Eleven, Inc.

Japan flag
Acquiror: 
Seven-Eleven Japan Co., Ltd

Advised the special committee of 7-Eleven, Inc. in connection with its evaluation of an unsolicited tender offer commenced by Seven-Eleven Japan Co., Ltd

08-Mar-04
$840 million
United States flag
Target: 

International Multifoods Corporation

United States flag
Acquiror: 
JM Smucker Company

Advised International Multifoods Corporation, whose brands include Pillsbury, Martha White, Hungry Jack and Robin Hood, on its sale to the J.M Smucker Company.

18-Mar-03
$7.0 billion
Germany flag
Target: 

Wella AG

United States flag
Acquiror: 
The Procter & Gamble Company

Advised Wella AG, a global market leader in hair care and fragrances, on its sale to The Procter & Gamble Company

13-Dec-02
$1.5 billion
U.S.A., U.K. flags
Target: 

Burger King Corp

United States flag
Acquiror: 
Texas Pacific Group, Bain Capital, Goldman Sachs Capital Partners

(subsidiary of Diageo plc) Advised Diageo plc on sale of Burger King Corporation restaurant system.

27-Mar-02
$168 million
United States flag
Target: 

Morton’s Restaurant Group Inc.

flag not available
Acquiror: 
Castle Harlan, Inc.

Advised the Special Committee of Morton’s on sale of the Company.

16-Jan-01
$11.5 billion
United States flag
Target: 

Ralston Purina Co.

Switzerland flag
Acquiror: 
Nestlé S.A.

Advised Nestlé on the agreed cash offer for the US pet-food company Ralston Purina

17-Jul-00
$10.5 billion
U.S.A., U.K. flags
Target: 

Diageo plc

United States flag
Acquiror: 
General Mills, Inc.

Advised Diageo on the sale of The Pillsbury Company for $5.1 billion in assumed debt and $5.4 billion in stock to General Mills.

16-Jan-98
$NA
United States flag
Target: 

Borden Foods International

Switzerland flag
Acquiror: 
Nestlé S.A.

Advised Nestlé on its acquisition of Borden Foods International’s businesses, which have sales of more than $400 million.

show 25 per page